FDA inspection
Chongqing Angelisun Pharmaceutical Co., Ltd.: FDA inspection ending Jan 17, 2025
FDA inspection 1259615 · Voluntary Action Indicated (VAI) · Chongqing
Key facts
| Inspection ID | 1259615 |
|---|---|
| Firm | Chongqing Angelisun Pharmaceutical Co., Ltd. |
| FEI number | 3014747080 |
| Address | No. 5 Huanan Road, Yanjia, Changshou |
| City | Chongqing |
| Country | China |
| Fiscal year | 2025 |
| Inspection end date | Jan 17, 2025 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data